ESC Heart Failure (Oct 2021)

Keeping immune checkpoint inhibitor myocarditis in check: advanced circulatory mechanical support as a bridge to recovery

  • Ashley F. Stein‐Merlob,
  • Jeffrey J. Hsu,
  • Bradley Colton,
  • Christopher J. Berg,
  • Allison Ferreira,
  • Megan M. Price,
  • Zev Wainberg,
  • Arnold S. Baas,
  • Mario C. Deng,
  • Rushi V. Parikh,
  • Eric H. Yang

DOI
https://doi.org/10.1002/ehf2.13545
Journal volume & issue
Vol. 8, no. 5
pp. 4301 – 4306

Abstract

Read online

Abstract Immune checkpoint inhibitor (ICI)‐associated myocarditis is a rare, potentially life‐threatening complication of immunotherapy. We report a case of a 60‐year‐old female with a history of colorectal cancer treated with nivolumab immunotherapy who presented with new cardiomyopathy complicated by cardiogenic shock and ventricular arrhythmias. Treatment of ICI‐associated myocarditis requires aggressive immunosuppression and supportive therapy. In this case, the patient required advanced mechanical circulatory support as a bridge to recovery. This case highlights the complexity of diagnosis, haemodynamic management, and treatment of fulminant ICI myocarditis.

Keywords